Bronchiectasis in patients with chronic obstructive pulmonary disease

Bronchiectasis in patients with chronic obstructive pulmonary disease

<p><strong>Background: </strong>Chronic obstructive pulmonary disease is most common disease entity and third leading cause of mortality worldwide. The presence of bronchiectasis in severe chronic obstructive pulmonary disease patients had led to frequent exacerbation requiring hos...

Full description

Bibliographic Details
Main Authors:	Milesh Jung Sijapati, Narayan Bikram Thapa, Rajendra Rijal, Shiva Raj KC, Poojyashree Karki
Format:	Article
Language:	English
Published:	Association of Clinical Pathologists of Nepal 2018-09-01
Series:	Journal of Pathology of Nepal
Subjects:	Bronchiectasis COPD Exacerbation Klebsiella Pneumoniae Obstructive Pseudomonas Aeruginosa
Online Access:	https://www.nepjol.info/index.php/JPN/article/view/20870

Similar Items

Favorable Response to Long-Term Azithromycin Therapy in Bronchiectasis Patients with Chronic Airflow Obstruction Compared to Chronic Obstructive Pulmonary Disease Patients without Bronchiectasis
by: Choi Y, et al.
Published: (2021-03-01)

Altered community compositions of Proteobacteria in adults with bronchiectasis
by: Guan WJ, et al.
Published: (2018-07-01)

Bronchiectasis: a bacteriological profile
by: Regis Gothard Bopaka, et al.
Published: (2015-12-01)

Assessment of Bronchiectasis Severity: The FACED Score versus The Bronchiectasis Severity Index (BSI)
by: Dr. Jitendrakumar A. Sisodia, et al.
Published: (2023-12-01)

Clinical Impact of the Bronchiectasis with Chronic Bronchitis Symptoms in COPD: Analysis of a Longitudinal Cohort
by: Kim EK, et al.
Published: (2021-11-01)

Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients
by: Kawamatawong T, et al.
Published: (2018-03-01)

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction
by: Hyo Jin Lee, et al.
Published: (2024-01-01)

The contribution of Pseudomonas aeruginosa infection to clinical outcomes in bronchiectasis: a prospective cohort study
by: Rongchun Wang, et al.
Published: (2021-01-01)

Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease
by: Fathia G. Jaat, et al.
Published: (2018-05-01)

Bronchiectasis in COPD patients: more than a comorbidity?
by: Martinez-Garcia MA, et al.
Published: (2017-05-01)

Factors affecting readmitted patients with acute exacerbation of bronchiectasis
by: Fatima Alhamed Alduihi, et al.
Published: (2019-01-01)

Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study
by: Julia C. Espel, et al.
Published: (2017-11-01)

Chronic Obstructive Pulmonary Disease Is Associated With Decreased Quality of Life in Bronchiectasis Patients: Findings From the KMBARC Registry
by: Sang Hyuk Kim, et al.
Published: (2021-08-01)

Chronic Obstructive Pulmonary Disease as a Phenotype of Bronchiectasis for Long-Term Clinical Presentation and Treatment
by: Chih-Yi Hsu, et al.
Published: (2021-06-01)

Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.
by: Christopher M. Blanchette, et al.
Published: (2017-09-01)

Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of <i>Pseudomonas aeruginosa</i>
by: Rosario Menéndez, et al.
Published: (2020-08-01)

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis
by: Ravishankar Chandrasekaran, et al.
Published: (2018-05-01)

Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study
by: Montón C, et al.
Published: (2019-10-01)

Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)
by: Amaia Artaraz, et al.
Published: (2020-01-01)

Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan
by: Chun-Yu Lin, et al.
Published: (2022-04-01)

Sputum Exosomal microRNAs Profiling Reveals Critical Pathways Modulated By Pseudomonas aeruginosa Colonization In Bronchiectasis
by: Huang Y, et al.
Published: (2019-11-01)

The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management
by: Martinez-Garcia MA, et al.
Published: (2022-03-01)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2023-06-01)

Coexistence of COVID-19, Pseudomonas, and thoracic actinomycosis in a cystic bronchiectasis case
by: Emine Afsin, et al.
Published: (2023-04-01)

Outcomes of lung transplantation in adults with bronchiectasis
by: Jodie Birch, et al.
Published: (2018-05-01)

Decreased Sphingosine Due to Down-Regulation of Acid Ceramidase Expression in Airway of Bronchiectasis Patients: A Potential Contributor to Pseudomonas aeruginosa Infection
by: Qi Q, et al.
Published: (2023-04-01)

Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
by: Hsieh MH, et al.
Published: (2018-08-01)

The incidence of bronchiectasis in chronic obstructive pulmonary disease
by: Lu Hsueh-Yi, et al.
Published: (2022-12-01)

High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk
by: Wang Chun Kwok, et al.
Published: (2024-02-01)

LONG-TERM AZITHROMYCIN TREATMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: Vanya Kostadinova, et al.
Published: (2020-07-01)

Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications
by: Gao YH, et al.
Published: (2018-01-01)

Chronic infection with non-tuberculous mycobacteria in patients with non-CF bronchiectasis: Comparison with other pathogens
by: Giulia Bonaiti, et al.
Published: (2015-01-01)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
by: Jacky Tu, et al.
Published: (2023-09-01)

In bronchiectasis, poor physical capacity correlates with poor quality of life
by: Jarkko Mäntylä, et al.
Published: (2022-12-01)

Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity
by: Miguel Ángel Martinez-García, et al.
Published: (2022-09-01)

Clinical impact of cardiovascular disease on patients with bronchiectasis
by: Shanshan Chen, et al.
Published: (2020-04-01)

Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis
by: Yang Liu, et al.
Published: (2021-10-01)

Identification of KPC-Producing Pseudomonas aeruginosa and Acinetobacter baumannii in a Burned Infant: A Case Report
by: Leila Azimi, et al.
Published: (2015-10-01)

Associational resistance to predation by protists in a mixed species biofilm
by: Goh, Yu Fen, et al.
Published: (2023)

Identification of KPC-Producing Pseudomonas Aeruginosa and Acinetobacter Baumanniiin a Burned Infant: A Case Report
by: Abdolaziz Rastegar Lari, et al.
Published: (2012-03-01)